Crossmark

Chemo-informatics activity prediction, ligand based drug design, Molecular docking and pharmacokinetics studies of some series of 4, 6-diaryl-2-pyrimidinamine derivatives as anti-cancer agents

Crossref DOI link: https://doi.org/10.1186/s42269-021-00631-w

Published Online: 2021-10-09

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abdullahi, Sagiru Hamza

Uzairu, Adamu

Ibrahim, Muhammad Tukur

Umar, Abdullahi Bello
License Information

Text and Data Mining valid from 2021-10-09

Version of Record valid from 2021-10-09
More Information

Article History

Received: 23 August 2021

Accepted: 27 September 2021

First Online: 9 October 2021

Declarations

:

: Not applicable, because this article does not contain any studies with human or animal subjects.

: Not applicable.

: The correspondents did not acknowledge competing of interest.

Document is current

Any future updates will be listed below